Phibro Animal Health (NASDAQ:PAHC) CEO Jack Bendheim Sells 8,801 Shares of Stock

Phibro Animal Health Corporation (NASDAQ:PAHC) CEO Jack Bendheim sold 8,801 shares of the stock in a transaction dated Thursday, November 13th. The stock was sold at an average price of $44.47, for a total transaction of $391,380.47. Following the transaction, the chief executive officer directly owned 5,240 shares of the company’s stock, valued at $233,022.80. This represents a 62.68% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Jack Bendheim also recently made the following trade(s):

• On Wednesday, November 12th, Jack Bendheim sold 21,536 shares of Phibro Animal Health stock. The stock was sold at an average price of $45.23, for a total value of $974,073.28.
• On Monday, November 10th, Jack Bendheim sold 38,303 shares of Phibro Animal Health stock. The stock was sold at an average price of $45.29, for a total value of $1,734,742.87.
• On Friday, November 7th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $42.86, for a total value of $150,867.20.
• On Tuesday, November 4th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $43.10, for a total value of $151,712.00.
• On Thursday, October 30th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $41.07, for a total value of $144,566.40.
• On Tuesday, October 28th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $41.56, for a total transaction of $146,291.20.
• On Thursday, October 23rd, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.18, for a total transaction of $141,433.60.
• On Wednesday, October 22nd, Jack Bendheim sold 11,859 shares of Phibro Animal Health stock. The shares were sold at an average price of $40.27, for a total transaction of $477,561.93.
• On Monday, October 20th, Jack Bendheim sold 16,075 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.38, for a total transaction of $649,108.50.
• On Friday, October 17th, Jack Bendheim sold 700 shares of Phibro Animal Health stock. The shares were sold at an average price of $40.03, for a total transaction of $28,021.00.

Phibro Animal Health Price Performance

Shares of NASDAQ:PAHC traded down $0.06 during trading on Friday, hitting $44.64. 39,016 shares of the stock were exchanged, compared to its average volume of 277,088. The company has a market cap of $1.81 billion, a PE ratio of 37.96, a P/E/G ratio of 1.24 and a beta of 0.81. The company has a current ratio of 2.76, a quick ratio of 1.25 and a debt-to-equity ratio of 2.46. The company has a fifty day moving average price of $40.32 and a two-hundred day moving average price of $31.62. Phibro Animal Health Corporation has a 12-month low of $16.16 and a 12-month high of $46.42.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings data on Wednesday, November 5th. The company reported $0.73 earnings per share for the quarter, beating the consensus estimate of $0.58 by $0.15. The firm had revenue of $363.89 million during the quarter, compared to the consensus estimate of $345.44 million. Phibro Animal Health had a return on equity of 32.14% and a net margin of 3.73%. Phibro Animal Health has set its FY 2026 guidance at 2.640-2.810 EPS. On average, analysts forecast that Phibro Animal Health Corporation will post 1.95 EPS for the current year.

Phibro Animal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 17th. Investors of record on Wednesday, November 26th will be paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date of this dividend is Wednesday, November 26th. Phibro Animal Health’s dividend payout ratio is presently 28.92%.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the stock. Bank of America lifted their target price on shares of Phibro Animal Health from $19.00 to $27.00 and gave the stock an “underperform” rating in a research report on Friday, August 29th. Morgan Stanley set a $34.00 target price on Phibro Animal Health in a report on Thursday, August 28th. Weiss Ratings reissued a “buy (b-)” rating on shares of Phibro Animal Health in a report on Tuesday. Zacks Research lowered Phibro Animal Health from a “strong-buy” rating to a “hold” rating in a research note on Monday. Finally, JPMorgan Chase & Co. lifted their price objective on Phibro Animal Health from $45.00 to $50.00 and gave the stock an “overweight” rating in a research report on Friday, November 7th. Two investment analysts have rated the stock with a Buy rating, four have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $31.40.

Hedge Funds Weigh In On Phibro Animal Health

Institutional investors and hedge funds have recently bought and sold shares of the stock. Financial Management Professionals Inc. purchased a new position in Phibro Animal Health during the second quarter worth approximately $32,000. National Bank of Canada FI purchased a new position in shares of Phibro Animal Health in the 1st quarter worth $30,000. iSAM Funds UK Ltd acquired a new position in Phibro Animal Health in the third quarter valued at $61,000. EverSource Wealth Advisors LLC grew its position in Phibro Animal Health by 7,671.4% during the second quarter. EverSource Wealth Advisors LLC now owns 2,720 shares of the company’s stock valued at $69,000 after acquiring an additional 2,685 shares during the period. Finally, Tower Research Capital LLC TRC increased its stake in Phibro Animal Health by 768.2% during the second quarter. Tower Research Capital LLC TRC now owns 4,610 shares of the company’s stock worth $118,000 after acquiring an additional 4,079 shares during the last quarter. Institutional investors and hedge funds own 99.34% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.